Spanish Pharma Stock News

Earnings snapshot and why it matters for Gestamp Automoción (BME:GEST) Gestamp Automoción (BME:GEST) has released full year 2025 earnings, reporting revenue of €11,622.27 million and net income of €152.21 million. Both figures are lower than the previous year, a result that can influence how investors reassess the stock. See our latest analysis for Gestamp Automoción. Gestamp Automoción’s share price has had a mixed pattern, with a 1-day share price return of 1.45% but a 7-day share price...

Full year 2025 results put profitability in focus Grifols (BME:GRF) has drawn fresh attention after reporting full year 2025 results, with sales of €7,524 million, net income of €402 million, and earnings per share from continuing operations of €0.59. See our latest analysis for Grifols. The earnings release and call on 26 February came against a weak backdrop for the shares, with a 1-day share price return of a 5.25% decline and a year-to-date share price return of a 10.92% decline, while...

Aena S.M.E (BME:AENA) has paired its full year 2025 earnings release with an annual dividend announcement of €0.8829 per share, putting both profit generation and cash returns in focus for shareholders. See our latest analysis for Aena S.M.E. The dividend and full year results land after a softer patch for the share price, with a 7.29% 7 day share price return decline and a 3.49% one day drop. However, longer term total shareholder returns of 21.81% over one year and 92.68% over five years...

Realia Business (BME:RLIA) has drawn fresh attention after reporting full year 2025 results, with sales of €123.19 million, revenue of €325.26 million, and net income of €129.4 million from continuing operations. See our latest analysis for Realia Business. Realia Business shares have edged higher to €1.03, with a 90 day share price return of 2.49% and a 5 year total shareholder return of 62.98%, suggesting momentum has been building alongside the latest earnings update. If this earnings...

Distribuidora Internacional de Alimentación (BME:DIA) has drawn investor attention after reporting full year 2025 results, with net income of €128.98 million compared with a net loss a year earlier. See our latest analysis for Distribuidora Internacional de Alimentación. The earnings turnaround arrives after a strong run in the shares, with a 25.51% 90 day share price return and a very large 1 year total shareholder return suggesting momentum has been building rather than fading. If this...

Almirall’s latest earnings and guidance trigger fresh focus on the stock Almirall (BME:ALM) has come into focus after reporting full year 2025 results alongside new 2026 guidance, combining higher sales, revenue and net income with an outlook for 9% to 12% net sales growth. See our latest analysis for Almirall. Despite the new 2026 guidance and the strong 2025 earnings update, Almirall’s recent momentum has cooled, with the share price at €12.02 and a 7 day share price return of a 6.39%...

Línea Directa Aseguradora Compañía de Seguros y Reaseguros (BME:LDA) recently reported fourth quarter net income of €26.04 million and full year 2025 net income of €85.71 million, drawing fresh attention to the stock. See our latest analysis for Línea Directa Aseguradora Compañía de Seguros y Reaseguros. Despite the latest earnings drawing attention, the current share price of €1.178 comes after a 9.25% 7 day share price decline. However, the 90 day share price return of 7.09% and 3 year...

Solaria Energía y Medio Ambiente recently reported that it exceeded its EBITDA guidance with €266M, scaled its operational portfolio to 3 GW, and secured long-term power purchase agreements, including a 40‑year solar contract and a 10‑year hybrid battery deal. Beyond the headline earnings beat, the acceleration in data center and battery‑related activity, underpinned by strong cash generation and European expansion, suggests that Solaria is increasingly positioning itself as an integrated...

In late February 2026, Banco Bilbao Vizcaya Argentaria, S.A. completed and announced several US$-denominated senior non-preferred note offerings totaling US$2.50 billion, spanning fixed and floating-rate Eurobond and Eurodollar issues maturing in 2029 and 2036. These issuances, coming soon after BBVA reported record 2025 profit on strong loan growth and efficiency gains, highlight how the bank is tapping bond markets to support its balance sheet and funding mix. We’ll now examine how...

Telefónica, through its nexfibre joint venture, announced the acquisition of UK fibre provider Substantial Group, aiming to expand fibre infrastructure in the UK. Telefónica Spain is adopting Red Hat OpenShift to modernize and unify IT and network functions across its operations. The company, listed as BME:TEF, last closed at €3.724. For investors watching BME:TEF, these moves come as the stock trades at €3.724, with a 9.0% return over the past 30 days and a 7.0% return year to date. The...

Naturgy Energy Group, S.A. has released its full-year 2025 results, reporting sales of €19,455 million and net income of €2,023 million, both higher than the prior year. This combination of slightly higher revenue and improved profitability highlights Naturgy’s ability to lift earnings even with relatively stable topline performance. We’ll now examine how this increase in full-year sales and net income could influence Naturgy’s existing investment narrative and risk balance. The future of...

Grifols, S.A. recently reported its full-year 2025 results, with sales rising to €7,524 million and net income reaching €402 million, lifting basic and diluted EPS from continuing operations to €0.59. The earnings release highlighted stronger profitability alongside revenue growth, suggesting that improved operations and product mix, including plasma-derived therapies, are becoming increasingly important to the business profile. We’ll now examine how this combination of higher revenue and...

Why Atresmedia’s latest results matter for shareholders Atresmedia Corporación de Medios de Comunicación (BME:A3M) has reported its 2025 results, highlighting revenue pressure from a weaker television advertising market, as well as record shareholder returns and a push into new media formats. See our latest analysis for Atresmedia Corporación de Medios de Comunicación. Atresmedia’s latest update comes after a mixed year in the market, with a 1-day share price return of 2.17% and a year to...

Corporación Acciona Energías Renovables, S.A. reported its full-year 2025 results on February 26, 2026, with sales of €2,925 million versus €3,048 million a year earlier, while net income rose to €655 million and basic earnings per share from continuing operations increased to €2 from €1.1. The combination of lower sales but much higher net income and earnings per share highlights a sharp improvement in underlying profitability and cost efficiency during 2025. With net income rising strongly...

Pharma Mar (BME:PHM) drew investor attention after its 2025 earnings call, where management highlighted a 27% revenue increase and a fivefold rise in EBITDA, largely tied to Zepzelca related milestones. See our latest analysis for Pharma Mar. The 1 day share price return of 1.52% to €80.25 comes after a steady 90 day share price return of 6.64%. However, the 1 year total shareholder return of a 15.4% decline shows recent enthusiasm has not fully reversed earlier weakness. If the Pharma Mar...

Grifols reported a solid revenue increase in 2025. The company improved free cash flow during the year. Grifols launched a new fibrinogen concentrate in Europe. A U.S. launch of the fibrinogen product is planned, pending FDA approval. For investors tracking Grifols (BME:GRF), the latest update combines financial progress with product news. The shares most recently traded at €10.63, with a 1% gain over the past year and a 45.4% decline over five years, highlighting how sentiment has shifted...

If you are wondering whether Repsol’s current share price reflects its real worth, you are not alone. Many investors are asking the same question. Repsol’s share price recently closed at €19.02, with returns of 3.9% over 7 days, 17.0% over 30 days, 15.9% year to date, 63.5% over 1 year, 46.2% over 3 years, and 121.7% over 5 years. This puts recent performance firmly on the radar for valuation focused investors. Recent headlines around Repsol have focused on its positioning in the energy...

Acciona (BME:ANA) is in focus after reporting full year 2025 results, with sales of €20,236 million, revenue of €22,441 million, and net income of €803 million compared with €422 million a year earlier. See our latest analysis for Acciona. The earnings release and news of Acciona’s role in Madrid’s largest public EV charging project have coincided with a sharp shift in sentiment, with a 36.6% 1 month share price return and a 113.7% 1 year total shareholder return suggesting strong recent...

If you are wondering whether Banco Santander's current share price offers value or is starting to look stretched, you are not alone. This article is here to unpack that question clearly. The stock recently closed at €10.79, with returns of 0.3% over 7 days, 1.8% over 30 days, 5.2% year to date and 77.7% over 1 year. The 3 year and 5 year returns of 211.4% and 318.6% indicate very large gains over those periods. Recent coverage of Banco Santander has focused on its position among European...

If you are wondering whether Técnicas Reunidas is still attractively priced after its recent run, you are not alone. This article is aimed squarely at that question. The stock most recently closed at €36.96, with returns of 5.0% over 7 days, 19.2% over 30 days, 30.8% year to date, 139.7% over 1 year and 253.5% over 3 years, which may affect how you think about its current risk and reward balance. Alongside these moves, investors have been reacting to ongoing project activity and contract...

Iberdrola (BME:IBE) just released its 2025 results, reporting sales of €45,546.8 million and net income of €6,285 million, supported by its networks business, revenue contribution from the UK and lower net debt. See our latest analysis for Iberdrola. The 2025 results land after a steady run in the market, with the latest share price at €20.05 and a 1 year total shareholder return of 48.35% that builds on a 5 year total shareholder return of 134.18%. If this earnings update has you thinking...

Metrovacesa earnings spark fresh interest in the stock Metrovacesa (BME:MVC) has attracted fresh attention after reporting full year 2025 net income of €56.86 million, compared with €15.89 million a year earlier, alongside higher basic and diluted earnings per share from continuing operations. See our latest analysis for Metrovacesa. The earnings release comes after a strong run in the shares, with a 30-day share price return of 30.26% and a 38.89% year to date share price return. The 5-year...

Ferrovial FY 2025 Results: Earnings Power Tested Against Softer Margins Ferrovial (BME:FER) just posted its FY 2025 numbers with first half revenue at €4.5b and basic EPS of €0.73, setting the tone for a year where investors are weighing current earnings against a richer valuation and softer profitability. The company has seen revenue move from €4.3b in 1H 2024 to €4.5b in 1H 2025, while basic EPS shifted from €0.56 to €0.73 over the same periods, with trailing twelve month EPS at €1.21 on...

If you are looking at Iberdrola and wondering whether the recent share price levels still make sense, focusing on value rather than just the story can help you frame that decision. The stock last closed at €20.05, with a 7 day return of a 0.2% decline, a 30 day return of 9.2%, a year to date return of 7.6% and a 1 year return of 49.1%, while the 3 year and 5 year returns sit at 105.1% and 130.1% respectively. These moves sit against a backdrop of ongoing interest in European utilities and...